The following data is part of a premarket notification filed by Randox Laboratories, Ltd. with the FDA for Randox Ecstasy (mdma) Assay.
Device ID | K092275 |
510k Number | K092275 |
Device Name: | RANDOX ECSTASY (MDMA) ASSAY |
Classification | Enzyme Immunoassay, Amphetamine |
Applicant | RANDOX LABORATORIES, LTD. 55 DIAMOND RD. Crumlin, County Antrim, GB Bt29 4qy |
Contact | P. Armstrong |
Correspondent | P. Armstrong RANDOX LABORATORIES, LTD. 55 DIAMOND RD. Crumlin, County Antrim, GB Bt29 4qy |
Product Code | DKZ |
Subsequent Product Code | DLJ |
Subsequent Product Code | LAS |
CFR Regulation Number | 862.3100 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2009-07-28 |
Decision Date | 2011-03-01 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
05055273208078 | K092275 | 000 |
05055273207941 | K092275 | 000 |
05055273207934 | K092275 | 000 |
05055273207859 | K092275 | 000 |